−/− (NSG) mice have advantages in establishing humanized mouse models. However, transferring human PBMCs into these mice often causes lethal GVH disease. In this study, we discovered an improved method for the engraftment of normal or pathological human PBMCs into NSG mice and examined the subsequent induction of specific immune responses. We sequentially transferred human CD4 + memory T (Tm)
Introduction
It has been difficult to reconstitute functional human immune systems in experimental mice primarily because of species specificity. NOD/Shi-scid/IL-2Rγ −/− (NOG) or NSG mice are severely immunodeficient because of their SCID mutation and IL-2 receptor common γ-chain deficiency [1, 2] . Due to their high engraftment rate with human-derived tissues, these mice have been useful for studying xenotransplantation [3, 4] and human immune Correspondence: Dr. Takashi Usui e-mail: takausui@kuhp.kyoto-u.ac.jp responses against viral infections [5] [6] [7] . Successful reconstruction of human immune systems in NOG mice was first accomplished by transferring HSCs [8] . Although multiple lineages of human lymphocytes could develop in situ [9, 10] , immune responses were still limited in these mice [9, 11, 12] . Indeed, several immunization challenges to the humanized NOG/NSG mice showed poor IgG production, which suggested that the interactions between human T and B cells were insufficient to activate the molecular machinery responsible for the class-switch recombination (CSR) of B cells. Successful reconstitution of human autoimmunity by transferring patient-derived PBMCs into experimental mice has been reported [13] . However, to our knowledge, there are no studies that have focused on the reconstitution of human autoimmunity using NOG/NSG mice. In addition, transferring PBMCs often causes lethal GVH disease (GVHD) in these mice, which makes long-term engraftment of human PBMCs and reconstitution of human immune systems difficult.
In the present study, we successfully engrafted PBMC-derived CD45RO + CD4 + memory T (Tm) and B cells obtained from adult humans into NSG mice without lethal GVHD. Subsequently, all isotypes of human Igs were produced de novo in these mice, which could be attributed to the interactions between the transferred Tm and B cells. We also transferred Tm and B cells obtained from patients with rheumatoid arthritis (RA) or antisynthetase syndrome into NSG mice and observed that sustained production of IgM-rheumatoid factor (RF) as well as antiaminoacyl-tRNA synthetase (ARS) Abs in these mice. These results suggest that the selective transfer of PBMC-derived Tm and B cells into these mice could be a useful method for the study of human autoimmune mechanisms.
Results

Removal of naïve T cells from donor PBMCs prevents GVHD-associated death in engrafted NSG mice
Because GVHD is a major issue that severely restricts the observation period in NSG mice after human PBMC-derived lymphocytes transfer, we first compared several conditions for the effective engraftment of human PBMCs. We prepared PBMC subfractions, whole PBMCs, naïve CD4 + T (Tn) cells, or Tm cells obtained from healthy donors. Cells of each subfraction were injected into NSG mice at 1 × 10 6 per mouse, and we compared the severity of GVHD among the groups. As shown in Figure 1A and B, the mice that received whole PBMCs or Tn cells lost body weight dramatically from approximately day 40 posttransfer, and did not survive beyond day 50 posttransfer. However, the mice that received Tm cells, despite showing mild GVHD that was histologically characterized by scattered or cluster-forming perivascular infiltration of human CD45 + cells in the affected organs (Fig. 1C) , did not lose body weight and survived longer than the other two groups. The percentage of human CD45 + cells in the total mouse mononuclear cells (% hCD45) in the peripheral blood (PB) tended to increase more significantly in whole PBMC-or Tn-cell-transferred mice than in Tm-cell-transferred mice prior to death. In the Tm-celltransferred group, the percent human CD45 continued to increase until approximately day 50 posttransfer and gradually decreased to low plateau levels; however, human CD45 + cells were still detectable on day 150 posttransfer (Fig. 1D, left) . In addition, FACS analysis showed a significant difference in the % hCD45 between the spleen and PB or BM in the terminal stages (days 180-250 posttransfer), which indicated that the transferred Tm cells had almost disappeared from the PB or BM but had preferentially resided in the spleen (Fig. 1D, right) . We further fractionated the Tm cells into central memory T cell and effector memory T-cell fractions and compared posttransfer changes, which showed no differences in body weight changes, survival, and serial changes in the % hCD45 in the PB from those of the Tm-cell-transferred mice (data not shown). Taken together, these results show that GVHD-associated death was avoidable by removing the Tn-cell fraction from the donor PBMCs.
Transferred Tm cells are functionally competent and can act as APCs
Because the diversity of the TCR repertoire is necessary for appropriate specific immune responses, we tested whether the transferred Tm cells had retained the diversity of the TCR repertoire in the engrafted mice. We performed spectratyping of CDR3 in the TCRβ chains and compared the diversity between the Tn and Tm cells, both of which were freshly obtained from PBMCs from the same donors as the transferred Tm cells and the Tm cells collected from the spleens of NSG mice on day 230 posttransfer. Though less diverse than T cells freshly obtained from the donors, the mouse-derived Tm cells still showed CDR3 diversity despite the passing of a significant amount of time after the transfer ( Fig. 2A) . We next performed intracellular cytokine staining (ICS) to test the cytokine secretion of the Tm cells collected from the PB of the engrafted mice on day 100 posttransfer and found that the transferred Tm cells could secrete significant levels of IFN-γ, IL-17, and IL-21 (Fig. 2B) . We further measured human IL-21 mRNAs in the Tm cells purified from the spleens and PB of the NSG mice on day 200 posttransfer as well as in freshly prepared Tn and Tm cells obtained from PBMCs of the same human donors. Interestingly, only the Tm cells in the spleens of the engrafted mice significantly expressed human IL-21 mRNAs (Fig. 2C ). This result indicated that the transferred Tm cells were constitutively activated and expressed high levels of IL-21 in the mouse spleen. We further tested whether the surface phenotypes of the Tm cells had changed after the transfer. In addition to the conventional markers, all the Tm cells collected from the mouse spleens on day 200 posttransfer expressed HLA-DR molecules, while most of the freshly isolated human PBMC-derived Tm cells did not (Fig. 2D) . Although mouse T cells do not normally express MHC class II molecules, most other species including humans do; thus, activated T cells can also act as APCs [14] . All these results suggested that most of the transferred Tm cells eventually subsided in the spleen without circulating in the PB long after the transfer and were constitutively activated to interact with other cells through both contact dependent and independent mechanisms.
Human B cells are efficiently engrafted into NSG mice by sequential transfer after Tm cells
Because IL-21 is important for B-cell maturation [15] , the result that the transferred Tm cells constitutively produced abundant human IL-21 in the spleens of Tm-cell-engrafted NSG mice was + cells in total mouse mononuclear cells (% hCD45) was determined by FACS in the indicated groups of mice at 7-day intervals (left). The % hCD45 in the spleen, PBMC, and BM of the Tm cell-engrafted mice was assessed by FACS on day 150 post-Tm-cell transfer (right). After the live lymphocytes were gated, the percentages of human or mouse CD45 + cells were determined by FACS. † Indicates the death of all mice within a group. The data are shown as mean ± SEM of five mice for each group from a single experiment representative of three independent experiments. The p value was determined using a Mann-Whitney U-test.
thought to be favorable for human B-cell engraftment. Thus, we hypothesized that sequential transfer of Tm and B cells could lead to effective engraftment of both cell populations. Furthermore, effective T-and B-cell interactions could induce specific immune responses with appropriate Ag stimulation. We purified PBMCderived B cells from the same Tm-cell donor and transferred 0.5 × 10 6 of the B cells per mouse into the NSG mice 60 days after the transfer of 1 × 10 6 Tm cells per mouse. In that period, the % hCD45 in the mouse PBMCs was at a low plateau level. Interestingly, all human Ig isotypes began to increase dramatically as early as day 7 post-B-cell transfer and continued to increase, reaching approximately one-fifth of the levels observed in humans (Fig. 3A , white circles). Among the IgG subclasses, IgG3 was the most abundant followed by IgG1, while IgG2 and IgG4 were relatively suppressed, which was different from the pattern observed in healthy humans [16] (Fig. 3B ). We also transferred allogeneic B cells, and compared the Ig production with an autologous B-cell transfer; the mice that received autologous B cells showed faster and greater human Ig production ( Fig. 3C ). In addition, IgE production was highly restricted in the allogeneic B-cell-transferred mice. Interestingly, the % hCD45 in mouse PBMCs was transiently re-elevated at approximately 20-30 days after the B-cell transfer in both the autologous and allogeneic B-cell-transferred mice (Fig. 3D, left) . Transferred B cells were initially detected in the PB (Fig. 3D, right) ; however, they gradually decreased and disappeared from the mouse PB (data not shown). On the other hand, plasma levels of human Igs remained at peak levels during the observation period. These results strongly suggested that like transferred Tm cells, transferred B cells also survived in the mouse spleen, and continued to produce large amounts of human Ig.
B cells transferred into NSG mice can survive only in the presence of Tm cells
Although both Tm and B cells gradually disappeared from the systemic circulation after the transfer, histological analyses of the spleens or, in some mice, the retroperitoneal lymphoid nodules on day 200 post-T-cell transfer (day 140 post-B-cell transfer) showed massive infiltration of human CD45 + cells, CD3 + cells, and CD20 + cells in these organs (Fig. 4A ). These human lymphocytes were also detected by FACS analyses of splenocytes ( Fig. 4B ). In addition, CD138 + plasmablasts/plasmacytes were also observed in the spleens and the lymphoid nodules (Fig. 4A ).
Although there was no apparent lymphoid follicle, the B cells and plasmablasts/plasmacytes formed proximal clusters with T cells distributed throughout the B-cell clusters. Professional APCs, monocytes and DCs, were not detected in any organs (data not shown), which ruled out the possible contamination of human APCs in the transferred cells. In the BM, some degree of T-cell infiltration was detected; however, B-cell infiltration was scarce and plasmablasts/plasmacytes were not detected in any of the mice (data not shown). To confirm the requirement for T-cell help for the B-cell engraftment, we transferred 0.5 × 10 6 purified B cells per mouse obtained from the same donors into NSG mice without a preceding Tm-cell transfer. Neither human CD45 + cells ( Fig. 4C and D) nor human Ig (Fig. 3A , black dots) was detected at any time (ßday 100). These results indicated that the sequential transfer of Tm and B cells into NSG mice led to the successful engraftment of both cell populations. Therefore, it was speculated that the strong and persistent T-and B-cell interactions continued to occur in the spleen and the lymphoid nodules of the engrafted mice.
B cells transferred into NSG mice undergo CSR in the lymphoid organs in the presence of Tm cells
The above results also strongly suggested that the transferred B cells were able to undergo CSR if the autologous Tm cells were co-localized in vivo. Thus, we performed histological analyses of the spleens and the lymphoid nodules obtained from NSG mice engrafted with allotype-matched Tm and B cells on day 200 post-T-cell transfer (on day 140 post-B-cell transfer); the scattered infiltration of activation-induced cytidine deaminase (AICDA) positive cells were observed in both the spleens and the lymphoid nodules (Fig. 5A ). In addition, AICDA and Iγ-Cμ circular transcripts (Iγ-Cμ CTs) were obtained by RT-PCR using RNA obtained from the same spleens as described above (NSG; Fig. 5B ). As was consistent with a previous report, AICDA mRNA was also detected in Jurkat cells [17] 5C ). These results indicated that the transferred B cells were able to undergo CSR in the presence of Tm cells as a result of the sustained T-and B-cell interactions in the lymphoid organs of the engrafted mice.
Human auto-Ab production is maintained after transfer of patient-derived Tm and B cells into NSG mice
Some auto-Abs are considered to have pathological roles in human autoimmune diseases [19] and to be produced by auto-reactive B-cell clones [20] . Thus, we considered whether it would be possible to maintain the production of human auto-Abs in NSG mice and to cause disease-specific pathologic changes by the transfer of PBMC-derived Tm and B cells obtained from patients with autoimmune diseases. We enrolled RA patients with IgM-RF and patients with antisynthetase syndrome, including a polymyositis patient with antihistidyl-tRNA synthetase (Jo-1) Ab and a dermatomyositis patient with antiglycyl-tRNA synthetase (EJ) Ab because corresponding Ags of these auto-Abs were thought to be highly homologous with those of mice, and these auto-Abs themselves may be pathological [21, 22] . All the mice survived during the observation period (17 weeks), and the % hCD45 in the mouse PBMCs changed in the same manner as observed in the healthy donor-derived Tm-and B-cell-transferred mice (data not shown). Interestingly, plasma levels of IgM-RF were gradually increased immediately after the transfer in the mice engrafted with Tm and B cells derived from RA patients (Fig. 6A,  right) , while IgM-RF was not detectable in the mice engrafted with Tm and B cells derived from patients with antisynthetase syndrome (Fig. 6A, left) . On the other hand, both IgG-anti-ARS Abs, anti-Jo-1 and anti-EJ Abs, were detected only immediately after the transfer and the titer decreased to below threshold levels within a few weeks (data not shown). We also then measured IgM-anti-ARS Abs. The mice engrafted with Tm and B cells derived from patients with antisynthetase syndrome showed high levels of plasma IgM-anti-ARS Abs, and the peak values were significantly elevated compared with those of the mice engrafted with Tm and B cells derived from RA patients (Fig. 6B, left) . However, in contrast with IgM-RF, the Ab-titers decreased gradually during the observation period (Fig. 6B, right) . We further performed a histological analysis to investigate pathological changes; some mice engrafted with RA patient-derived Tm and B cells showed histological joint destruction, and some mice engrafted with antisynthetase syndrome patient-derived Tm and B cells showed minute infiltration of human lymphocytes in the leg muscle (Supporting Information Fig. 1 ). However, these findings were not consistent through the engrafted mice and were difficult to distinguish from the changes detected in chronic GVHD. Taken together, these results indicated that the production of some types of human auto-Abs, especially IgM-Abs, can be maintained in NSG mice by transferring patient-derived Tm and B cells.
Discussion
We sequentially transferred human PBMC-derived Tm and B cells into NSG mice and achieved functional engraftment of these cells. Although lethal GVHD is a major problem in using PBMCs as sources of grafts, we were able to avoid this by simply removing the Tn-cell fraction from the donor PBMCs. Because Ag-specific pathological T cells should be in the Tm-cell fraction and an aberrant or skewed T-cell population has also been observed in the Tm-cell fraction in various human autoimmune diseases such as RA [23] , our strategy had advantages to increase the chance for selective expansion of pathological T cells in engrafted mice.
Although both transferred Tm and B cells gradually disappeared from the PB after the transfer, they resided in the spleen and the lymphoid nodules and survived for several months. Interestingly, histological study of the lymphoid nodules of Tm-and B-cell-transferred mice revealed a characteristic distribution of T cells, B cells, and plasma cells (Fig. 4A) : T cells were distributed in a scattered manner, B cells formed clusters, and plasmablasts/plasmacytes localized just outside the B-cell clusters. This characteristic cell distribution was similar to that of the secondary lymphoid organ and indicated the interactions among these cells. On the other hand, plasmacytes were not detected in the BMs and most of the infiltrating cells were CD4 + T cells. We also sequentially transferred Tm and naïve B cells instead of total B cells. However, it was technically difficult to obtain sufficient naïve B cells due to their adherent properties, and transferred naïve B cells failed to engraft (data not shown). Although we acknowledge the absence of definitive evidence of an interaction between the transferred Tm and B cells, the data presented in this study are convincing. First, the transferred B cells were not maintained without a preceding Tm-cell transfer, while they were well maintained in the presence of the engrafted Tm cells. Second, transferred B cells underwent de novo CSR, which resulted in the production of all isotypes of human Ig at significant levels. Third, allotype-matched Tm-and B-cell transfers resulted in significant and more rapid human Ig production than that observed in the case of allotype-unmatched transfers. Fourth, because human IL-21 strongly induces IgG1-and IgG3-producing CSR in concert with CD40-CD40L interactions [24] , the observation that the transferred Tm cells constitutively secreted high amount of IL-21 in the spleen might explain why IgG3 was the dominant subclass of IgG in the engrafted mouse. Fifth, professional APCs were not detected in the mice; rather, transferred Tm cells expressed HLA-DR molecules and maintained TCR diversity even 7-8 months after the transfer, which suggested that activated Tm cells also acted as APCs in the engrafted mouse. All these data strongly suggested that the strong and persistent interaction between the transferred Tm and B cells resulted in the reconstruction and the persistence of this quasi-human immune system in the engrafted mice. However, to obtain definitive evidence of T-cell-dependent B-cell differentiation and specific Ab production in these mice, immunization studies using appropriate Ags need to be performed. Based on these findings, we tried to induce Ag-specific auto-Ab production in NSG mice using PBMCs obtained from autoimmunedisease patients. Transferring PBMC-derived Tm and B cells obtained from RA patients with IgM-RF led to the sustained production of IgM-RF in the transferred mice, and the titers continued to increase during the observation period, which was not observed in the case of transfer of Tm and B cells obtained from IgM-RF negative patients. Because corresponding IgM-RF Ags are IgG Fc fragments or denatured IgG molecules [25] , which were continuously supplied by the transferred B cells, it is reasonable that IgM-RF-producing B-cell clones were maintained in the presence of Ag-specific Tm cells in these mice. On the other hand, IgGand IgM-anti-ARS Abs were only transiently detected after the transfer of Tm and B cells derived from PBMCs of patients with antisynthetase syndrome, and the titers were gradually decreased to below the threshold levels of measurement. This might be attributable to the absence of corresponding Ags despite myositisspecific Ags; notably ARS shows high homology between human and mice. It is also known that the Ab responses against Jo-1 show remarkable species specificity [26] . Thus, it is speculated that the minute differences in the Ag-epitopes between mice and humans resulted in a failure of the persistent interaction between human ARS-specific Tm and B cells. The absence of long-lived plasmacytes in the BMs of the engrafted mice might also explain the inadequate production of anti-ARS Abs.
Successful engraftment and the induction of Ag-specific humoral immune responses using HLA-DR Tg/mouse MHC class II KO NOG mice in combination with HSC transplant has also been reported [27] . However, the Ag-specific IgG production was poor, and the T-cell functions in vitro were greatly impaired. In addition, because the emergence of pathological autoimmune cells is known to be induced by a malfunction of peripheral tolerance, but not by central tolerance [28] , HSC transfer will not be able to reconstitute the same autoimmunity as donor patients in these mice. Therefore, it is possible that PBMCs are more suitable grafts for the reconstitution of human autoimmune systems in these mice.
Several groups have reported mouse models of human immune diseases, such as systemic lupus erythematosus, antiphospholipid syndrome [13] , ulcerative colitis [29] , or Stevens-Johnson/toxic epidermal syndrome [30] using patient-derived PBMCs. In systemic lupus erythematosus and antiphospholipid syndrome models, PBMC-transferred BALB-RAG-2 −/− IL-2R −/− mice showed anti-DNA Ab production in the sera and presented human diseaselike lesions, such as nephritis or multiple thrombi. In ulcerative colitis or Stevens-Johnson/toxic epidermal syndrome models, PBMCtransferred NOG mice were challenged with specific Ags and subsequently developed human disease-like lesions. These models are thought to be valuable because they provide patient-specific disease models and because the same pathologies the donor patients experience are induced in the mice using patients-derived PBMCs. However, careful validation of Ag specificity or a clear distinction between the induced immunological pathology and chronic GVHD is necessary. The mechanisms of production or pathogenic roles of many auto-Abs, including RF, have yet to be determined. Recently, unique mechanisms of RF production in association with IgGheavy chain presented by certain HLA-DR molecules have been suggested [31] . Because IgM-RF production is able to be maintained in our model, our methods may provide a useful approach to clarify the precise mechanism of IgM-RF production and its pathological role.
In conclusion, we successfully reconstituted human immune systems in NSG mice using human PBMC-derived Tm and B cells and clarified important points for the effective engraftment and induction of Ag-specific immune responses. We expect to be able to establish more sophisticated human immune systems in this mouse strain using human PBMCs with further improvements.
Materials and methods
Animals
Six-to 8-week-old NSG mice were purchased from the Jackson Laboratory and maintained in our animal facility under specific pathogen-free conditions. All the animal procedures were approved by the Animal Experimental Committee of Kyoto University (MedKyo 12120).
Preparation of human PBMCs
PBMCs were separated from the PB of healthy donors or patients with autoimmune diseases using Lymphocyte Separation Solution (Nacalai) by density centrifugation. Human CD45RA + CD4
+
Tn cells or CD45RO + CD4 + Tm cells were purified by positive selection using anti-CD45RA or anti-CD45RO MicroBeads followed by negative selection using anti-CD20 MicroBeads and finally sorted by FACS Aria II (BD Bioscience) using anti-CD4-allophycocyanin (BioLegend), anti-CD8a-FITC (BioLegend), and anti-CD19-phycoerythrin (PE; eBioscience). Central memory T cells or effector memory T cells were isolated using a CD4 + Central or Effector Memory T Cell Isolation MicroBeads
Kit and purified by FACS Aria II as described above. Human B cells were obtained and purified from the same or different donors as the Tm cells by negative selection using anti-human CD2 MicroBeads followed by sorting with FACS Aria II using anti-CD45-Pacific blue (eBioscience), anti-CD19-biotin detected by streptavidin-allophycocyanin/Cy7 (eBioscience), and anti-CD3-PE/Cy7 (BioLegend). The postsort purities of the CD45RA + CD4 + ,
and CD19 + cells were >99%, and the obtained cells were injected intraperitoneally into NSG mice. The number of injected whole PBMCs or T cells was 1 × 10 6 per mouse, and the number of B cells was 0.5 × 10 6 per mouse. All MicroBeads used in the study were purchased from Miltenyi Biotec. All the donors were adults who had provided written informed consent. The study was approved by the Institutional Review Board of the Graduate School of Medicine, Kyoto University and Kyoto University Hospital. All the patients had active disease and had high serum titers of disease-associated auto-Abs.
Flow cytometry
PB was taken from the mouse tail vein at 7-day intervals after the transfer, and plasma and blood cells were separated by density centrifugation. Single-cell suspensions were prepared from the mouse spleens and PBMCs after red blood cell lysis with ammonium-chloride-potassium buffer. Lymphocytes were stained with anti-mouse CD45-biotin (eBioscience) and detected by streptavidin-allophycocyanin/Cy7 and the following anti-human Abs: anti-CD45-Pacific Blue, antihuman leukocyte Ag HLA-DR-biotin (BioLegend) detected by streptavidin-allophycocyanin/Cy7, anti-CD3-PE/Cy7, anti-CD4-allophycocyanin, anti-CD8a-FITC, and anti-CD19-PE. The surface markers were analyzed by FACS LSR Fortessa (BD Bioscience), and the data were analyzed using FlowJo (Tree Star).
For ICS, Tm cells were isolated from the PBMCs of Tm-cellengrafted mice on day 100 posttransfer by positive selection using human memory CD4 + T-cell isolation Microbeads. The cells were stimulated with 20 ng/mL PMA and 1 μM ionomycin for 5 h and ICS was performed as described previously [32] using anti-human-IFN-γ-allophycocyanin (eBioscience), anti-human-IL-17-FITC (eBioscience), and anti-human-IL-21-biotin (BioLegend) detected by streptavidin-allophycocyanin/Cy7. Surface markers were also co-stained as described above.
ELISA
Human Igs and IgG subclasses in the mouse plasma and human IL-21 in the mouse spleens and plasma were measured using ELISA kits (Bethyl Laboratories, Life Technologies, eBioscience) according to the manufacturers' instructions.
Human auto-Abs in mouse plasma
IgM-RF was measured using a latex agglutination kit (Sysmex). IgG-anti-ARS Abs, which includes anti-Jo-1 Ab and anti-EJ Ab, were measured using ELISA kits (MBL) [33] . IgM-anti-ARS Abs were measured by performing an ELISA using anti-human IgM Abs (Bethyl Laboratories) as detection Abs.
Histology
Paraformaldehyde-fixed paraffin-embedded sections were stained with H&E. After treatment with heated citrate buffer for Ag retrieval, immunohistochemical staining was performed with mouse anti-human-CD45, mouse anti-human CD20 (Dako), mouse anti-human-CD3 (Leica Biosystems), mouse anti-human-CD138 (Nichirei Biosciences) Abs, and corresponding HRPconjugated anti-mouse IgG isotypes (Dako). Some specimens were also immunohistochemically stained with a rat anti-human-AICDA Ab and an HRP-conjugated rat IgG2a kappa isotype control (eBioscience).
Cell culture
Human B cells were obtained from the PBMCs of healthy donors by positive selection using anti-human-CD20 MicroBeads. Twelvewell culture plates were pretreated with 1 μg/mL anti-human CD40L (eBioscience) and 1 μg/mL anti-human-IgM Ab (BioLegend). One million cells per well were cultured in 1 mL RPMI-1640 complete medium (Gibco) in the presence of 20 ng/mL IL-21 (Cell Signaling Technology), 10 ng/mL IL-4 (Life Technologies), and 10 ng/mL LPS (Sigma-Aldrich) at 37°C in a 5% CO 2 incubator [18] . To confirm CSR of the cultured B cells, we assessed the surface markers on sequential days from days 0 to 8 using anti-CD3-PE/Cy7, anti-CD138-FITC (BioLegend), and anti-CD19-biotin detected by streptavidin-allophycocyanin/Cy7 and determined that the cells on day 8 were the most enriched for CD19 ± CD138 + plasmablasts/plasmacytes. After the cells were collected on day 8, total RNA and genomic DNA were extracted using ISOGEN (Nippon Gene) and DNeasy (Qiagen) kits, respectively. The obtained RNA was treated with TURBO TM DNase (Life Technologies) and, purified with an RNeasy Mini Kit (Qiagen).
PCR
RT-PCR was performed as follows. After isolation and purification of total RNA obtained from mouse spleens or PBMCs, firststrand complementary DNA was synthesized using Superscript III Reverse Transcriptase and random primers (Life Technologies). The synthesized first-strand complementary DNA was amplified using a Mastercycler ep (Eppendorf), with iProof TM High-Fidelity DNA Polymerase (BioRad) for beta actin, AICDA, and Iγ-Cμ CTs using gene-specific primers. Real-time PCR was performed in a Light Cycler 480 (Roche Applied Science) using universal probe library sets for human and gene-specific primers for IL-21 and GAPDH. Genomic DNA was also isolated using a DNeasy kit, and S H -S H scDNAs were amplified by nested PCR as described previously [18] ; a human-IL-6 gene locus was amplified as a positive control. We used Jurkat cells (RIKEN, Bio-Resource Center) as a non-B-cell control. For a CSR positive control, we used human PBMC-derived B cells cultured as described above. Genomic DNA obtained from freshly isolated human PBMC-derived B cells was used as a negative control.
To analyze the TCR repertoire diversity, we performed spectratyping of CDR3 in TCRβ chains by nested PCR as described previously [34] after obtaining genomic DNA from the Tm and Tn cells freshly isolated from the PBMC donor, and the Tm cells collected from NSG spleens on day 230 posttransfer. Primer pairs used in this study are listed in Supporting Information Table 1 .
DNA cloning and sequencing
PCR products or DNA bands purified from agarose gels were cloned using Zero Blunt PCR Cloning Kits (Life Technologies). Plasmids were isolated using a QIAprep Miniprep kit (Qiagen), and DNA sequencing was performed on a 3130xl Genetic Analyzer using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems).
Statistical analysis
A Mann-Whitney U-test was used for two-group comparisons, Kruskal-Wallis and Shirley-Williams posthoc tests were used for multiple group comparisons, and the log-rank test was used for the comparison of survival curves. Error bars in all the figures indicate the SEM. p values < 0.05 were considered statistically significant.
